Sofia Sigra Stein
Sofia Sigra Stein Position: Adjunct Lecturer School/office: School of Medical SciencesEmail: c29maWEuc2lncmE7b3J1LnNl
Phone: No number available
Room: -
About Sofia Sigra Stein
Sofia Sigra Stein is a resident in clinical pharmacology at the University Hospital in Örebro and an adjunct lecturer and PhD student at the School of Medical Sciences at Örebro University.
Research
Sofia does her research in immunopsychiatry with focus on evaluating the effect of immunomodulatory treatment on severe schizophrenia and OCD, where other therapies have failed.
Sofia has previously done research on the child- and adolescent psychiatric disorders PANDAS (Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal infections) and PANS (Pediatric Acute-onset Neuropsychiatric Syndrome).
Teaching
Sofia teaches in clinical pharmacology for, among others, medical students and is involved in designing the pharmacology curriculum for the new six-year Programme in Medicine. She has also served as a PBL-tutor across several terms and has co-supervised independent student projects within the Programme in Medicine.
Research projects
Completed projects
Publications
Articles in journals
- Bejerot, S. , Sigra, S. , Welin, E. , Eklund, D. , Hylén, U. & Humble, M. B. (2023). Rituximab as an adjunctive treatment for schizophrenia spectrum disorder or obsessive-compulsive disorder: Two open-label pilot studies on treatment-resistant patients. Journal of Psychiatric Research, 158, 319-329. [BibTeX]
Articles, reviews/surveys
- Sigra, S. , Hesselmark, E. & Bejerot, S. (2018). Treatment of PANDAS and PANS: a systematic review. Neuroscience and Biobehavioral Reviews, 86, 51-56. [BibTeX]
Conference papers
- Humble, M. B. , Eklund, D. , Fresnais, D. , Hylén, U. , Sigra, S. , Thunberg, P. & Bejerot, S. (2023). Rituximab for treatment-resistant schizophrenia and/or obsessive-compulsive disorder (OCD): functional connectivity and cytokines associated with symptomatic improvements. In: European psychiatry. Paper presented at 31st European Congress of Psychiatry (EPA 2023), Paris, France, March 25-28, 2023. (pp. S629-S629). Cambridge University Press. [BibTeX]